Portable coagulometers: A systematic review of the evidence on self-management of oral anticoagulant treatment;Coagulómetros portátiles: Una revisión sistemática de la evidencia científica del autocontrol del tratamiento anticoagulante oral

Medicina Clinica

Volumn 124, Issue 9, 2005, Pages 321-325

  De Solà Morales Serra, Oriol ^a,c   Elorza Ricart, Josep Maria ^b  

^a Catalan Agency for Health Technology Assessment and Research   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Parc Sanitari Pere Virgili   (Spain)

Author keywords

Anticoagulants; Point of care; Quality; Review; Scientific evidence

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BIBLIOGRAPHIC DATABASE; CLINICAL RESEARCH; CLINICAL TRIAL; COCHRANE LIBRARY; DEVICE; DRUG EFFICACY; HUMAN; MEDLINE; OUTCOMES RESEARCH; PATIENT CARE; PATIENT SELECTION; PORTABLE COAGULOMETER; SELF MEDICATION; SYSTEMATIC REVIEW; THROMBOSIS; TREATMENT OUTCOME;

EID: 17644423971     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13072418     Document Type: Article

References (28)

1. Vacas M, Lafuente PJ, Cuesta S, Iriarte JA. Comparative study of a portable monitor for prothrombin time determination, Coaguchek, with three systems for control of oral anticoagulant treatment. Haemostasis. 1998;28:321-8.
2. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323:334-6.
3. Cromheecke ME, Levi M, Colly LP, De Mol BJ, Prins MH, Hutten BA, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised crossover comparison. Lancet. 2000;356:97-102.
4. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA. 1999;281:145-50.
5. Fitzmaurice DA, Murray ET, Gee KM, Allan TF, Hobbs FD. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol. 2002;55:845-9.
6. White RH, McCurdy SA, Von Marensdorff H, Woodruff DE Jr, Leftgoff L. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med. 1989;111:730-7.
7. Fitzmaurice DA, Hobbs FD, Murray ET, Holder RL, Allan TF, Rose PE. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial. Arch Intern Med. 2000;160:2343-8.
8. Sidhu P, O'Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg. 2001;72:1523-7.
9. Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg. 2001;72:44-8.
10. Watzke HH, Forberg E, Svolba G, Jiménez-Boj E, Krinninger B. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost. 2000;83:661-5.
11. Hasenkam JM, Kimose HH, Knudsen L, Gronnesby H, Halborg J, Christensen TD, et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg. 1997;11:935-42.
12. Hasenkam JM, Knudsen L, Kimose HH, Gronnesby H, Attermann J, Andersen NT, et al. Practicability of patient self-testing of oral anticoagulant therapy by the international normalized ratio (INR) using a portable whole blood monitor. A pilot investigation. Thromb Res. 1997;85:77-82.
13. Christensen TD, Attermann J, Pilegaard HK, Andersen NT, Maegaard M, Hasenkam JM. Self-management of oral anticoagulant therapy for mechanical heart valve patients. Scand Cardiovasc J. 2001;35:107-13.
14. Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med. 1995;155:2185-9.
15. Erdman S, Vidne B, Levy MJ. A self control method for long term anticoagulation therapy. J Cardiovasc Surg (Torino). 1974;15:454-7.
16. Cosmi B, Palareti G, Moia M, Carpenedo M, Pengo V, Biasiolo A, et al. Accuracy of a portable prothrombin time monitor (Coagucheck) in patients on chronic oral anticoagulant therapy: a prospective multicenter study. Thromb Res. 2000;100:279-86.
17. Van den Besselaar AM, Meeuwisse-Braun J, Schaefer-van Mansfeld H, Van Rijn C, Witteveen E. A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device. Blood Coagul Fibrinolysis. 2000;11:559-62.
18. Gosselin R, Owings JT, White RH, Hutchinson R, Branch J, Mahackian K, et al. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost. 2000;83:698-703.
19. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17:1-12.
20. Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, et al. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981;2:31-49.
21. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group. N Engl J Med. 1995; 333:5-10.
22. Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis. 2000;9:283-92.
23. Booth L, Clegg A, Sands G. Achieving home-based care for deep vein thrombosis. Community Nurse. 1999;5:23-4.
24. Soto Álvarez J, Fernández Cano P. Analysis of the economic evaluation of drugs in primary care: concept, methodology and practical applications. Aten Primaria. 1997;20:563-8.
25. Koefoed BG, Petersen P. Oral anticoagulation in nonvalvular atrial fibrillation. J Intern Med. 1999; 245:375-81.
26. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996;348:423-8.
27. Executive Steering Committee on behalf of the SPORTIF III Investigators. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet. 2003;362: 1691-8.
28. Schulman S, Wahlander K, Lundstrom T, Clason SB, Eriksson H. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med. 2003;349: 1713-21.